Stay updated on ADXS-NEO Personalized Tumor Antigens Clinical Trial
Sign up to get notified when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.

Latest updates to the ADXS-NEO Personalized Tumor Antigens Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a centralized Locations section listing Arizona, California, Louisiana, and New Jersey; removed individual state location pages and the HHS Vulnerability Disclosure link, updating to Revision: v3.3.3.SummaryDifference0.5%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedPublications section wording updated to 'results of the study' and revision tag updated from v3.2.0 to v3.3.2; this is a minor editorial change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe banner about government funding lapse/operating status has been removed; no study details or eligibility information are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedNo significant additions or deletions detected on the page; observed changes appear to be minor UI or wording updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check92 days agoChange DetectedMajor change: page now advertises a government operating status notice and updates the release version to v3.2.0; previous v3.1.0 label was removed.SummaryDifference2%

- Check99 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to ADXS-NEO Personalized Tumor Antigens Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS-NEO Personalized Tumor Antigens Clinical Trial page.